Impact of Errors and Variability on Clinical Laboratory Test Interpretation

Test results generated in the clinical laboratory are used to inform medical decisions on a daily basis. When used properly, laboratory testing provides critically important information that allows clinicians to screen, diagnose, and monitor patients. When performed improperly at any stage in the testing process (preanalysis, during analysis, or postanalysis), laboratory tests can produce misleading results that endanger the health and safety of the patient. Prior to ordering a laboratory test, clinicians should understand the test's capabilities and inherent limitations. Biological variation of the analyte being measured, analytic error, sensitivity, specificity, and predictive value must all be considered when interpreting a laboratory test in the proper patient context. This article describes common pitfalls encountered during the laboratory testing process and discusses established practices that help maximize the benefits of clinical laboratory test results.

[1]  J O Westgard,et al.  European specifications for imprecision and inaccuracy compared with operating specifications that assure the quality required by US CLIA proficiency-testing criteria. , 1994, Clinical chemistry.

[2]  P. Li,et al.  Mechanism of interference by hemoglobin in the determination of total bilirubin. I. Method of Malloy-Evelyn. , 1980, Clinical chemistry.

[3]  B. Nordestgaard,et al.  Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study. , 2011, Clinical chemistry.

[4]  M. Zweig,et al.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.

[5]  D. Mutch Ovarian cancer: to screen or not to screen. , 2009, Obstetrics and gynecology.

[6]  G J Kost,et al.  Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. , 2009, Archives of pathology & laboratory medicine.

[7]  Yasmin S. Hamirani,et al.  Safety of statins: effects on muscle and the liver. , 2005, Cleveland Clinic journal of medicine.

[8]  D. Rudman,et al.  Transport of drugs, hormones and fatty acids in lipemic serum. , 1972, The Journal of pharmacology and experimental therapeutics.

[9]  Stuart R Lipsitz,et al.  Reduction in specimen labeling errors after implementation of a positive patient identification system in phlebotomy. , 2010, American journal of clinical pathology.

[10]  C. Fraser Improved monitoring of differences in serial laboratory results. , 2011, Clinical chemistry.

[11]  J. Cleeman,et al.  Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. , 1993, JAMA.

[12]  J. Ladenson,et al.  Patients as their own controls: use of the computer to identify "laboratory error". , 1975, Clinical chemistry.

[13]  G. Umpierrez,et al.  Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects , 2003, International Journal of Obesity.

[14]  F. Fonseca-Wollheim,et al.  Preanalytical Increase of Ammonia in Blood Specimens from Healthy Subjects , 1990 .

[15]  C. Schmid,et al.  Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. , 2011, Kidney international.

[16]  Samia Mora,et al.  Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events , 2008, Circulation.

[17]  J. Cleeman,et al.  The prevalence of high blood cholesterol levels among adults in the United States. , 1989, JAMA.

[18]  D S Young,et al.  Effects of Drugs on Clinical Laboratory Tests , 1997, Clinical chemistry.

[19]  Brennan,et al.  Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. , 1987, Clinical chemistry.

[20]  L J Kricka,et al.  Human anti-animal antibody interferences in immunological assays. , 1999, Clinical chemistry.

[21]  B. Nordestgaard,et al.  Fasting and Nonfasting Lipid Levels: Influence of Normal Food Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular Risk Prediction , 2008, Circulation.

[22]  R. F. Roberts,et al.  Comparison of serum and heparinized plasma samples for measurement of chemistry analytes. , 2004, Clinical chemistry.

[23]  V. Narra,et al.  Clinical and economic impact of falsely decreased calcium values caused by gadoversetamide interference. , 2008, AJR. American journal of roentgenology.

[24]  D. Bruns,et al.  Stabilization of glucose in blood specimens: mechanism of delay in fluoride inhibition of glycolysis. , 2008, Clinical chemistry.

[25]  T. Daly,et al.  Mechanisms of dopamine and dobutamine interference in biochemical tests that use peroxide and peroxidase to generate chromophore. , 1998, Clinical chemistry.

[26]  H. P. Kang,et al.  Model for predicting the impact of gadolinium on plasma calcium measured by the o-cresolphthalein method. , 2004, Clinical chemistry.

[27]  P. Calmarza,et al.  Lipemia interferences in routine clinical biochemical tests. , 2011, Biochemia medica.

[28]  A. Jaffe,et al.  Catecholamine interference in enzymatic creatinine assays. , 2009, Clinical Chemistry.

[29]  G. Eknoyan,et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  A. Dofferhoff,et al.  Pseudohyperkalemia and platelet counts. , 1991, The New England journal of medicine.

[31]  Greg Ward,et al.  Interferences in immunoassay. , 2004, The Clinical biochemist. Reviews.

[32]  K. Kent,et al.  Gadodiamide administration causes spurious hypocalcemia. , 2003, Radiology.

[33]  M H Kroll,et al.  Mechanism of interference with the Jaffé reaction for creatinine. , 1987, Clinical chemistry.

[34]  M. Schambelan,et al.  Pseudohyperkalemia caused by fist clenching during phlebotomy. , 1990, The New England journal of medicine.

[35]  Callum G Fraser,et al.  Reference change values , 2012, Clinical chemistry and laboratory medicine.

[36]  M H Kroll,et al.  Interference with clinical laboratory analyses. , 1994, Clinical chemistry.

[37]  H. Black,et al.  Racial differences in serum creatine kinase levels. , 1986, The American journal of medicine.

[38]  G. Horowitz Establishment and Use of Reference Values , 2012 .

[39]  R. Pierre,et al.  Pseudothrombocytopenia: a laboratory artifact with potentially serious consequences. , 1984, Mayo Clinic proceedings.

[40]  S. Fortmann,et al.  Population frequency distribution of non-high-density lipoprotein cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988-1994). , 2000, The American journal of cardiology.

[41]  D. Arber,et al.  Quality management in the transfusion service: case studies in process improvement , 2011, Transfusion.

[42]  P. Ridker,et al.  Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. , 2007, JAMA.

[43]  A. Wu,et al.  Bilirubin interference with determination of uric acid, cholesterol, and triglycerides in commercial peroxidase-coupled assays, and the effect of ferrocyanide. , 1986, Clinical chemistry.

[44]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[45]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[46]  L. Kricka,et al.  Interference by human anti-mouse antibody in two-site immunoassays. , 1990, Clinical chemistry.

[47]  B. Astor,et al.  Age and association of kidney measures with mortality and end-stage renal disease. , 2012, JAMA.

[48]  C Ricós,et al.  Current databases on biological variation: pros, cons and progress. , 1999, Scandinavian journal of clinical and laboratory investigation.

[49]  J O Westgard,et al.  Criteria for judging precision and accuracy in method development and evaluation. , 1974, Clinical chemistry.

[50]  J O Westgard,et al.  Allowable imprecision for laboratory tests based on clinical and analytical test outcome criteria. , 1994, Clinical chemistry.